Geneos Wealth Management Inc. Galectin Therapeutics Inc Call Options Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GALT
# of Institutions
96Shares Held
11.1MCall Options Held
136KPut Options Held
370K-
Vanguard Group Inc Valley Forge, PA2.18MShares$8.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$5.9 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.19MShares$4.49 Million0.01% of portfolio
-
Jane Street Group, LLC New York, NY749KShares$2.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$2.51 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $224M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...